DongKoo Bio&Pharma Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 4.28%

DongKoo Bio&Pharma Co. Ltd (006620) has an Asset Resilience Ratio of 4.28% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check DongKoo Bio&Pharma Co. Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩11.52 Billion

≈ $7.81 Million USD Cash + Short-term Investments

Total Assets

₩269.00 Billion

≈ $182.30 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how DongKoo Bio&Pharma Co. Ltd's Asset Resilience Ratio has changed over time. See debt-free asset ratio of DongKoo Bio&Pharma Co. Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down DongKoo Bio&Pharma Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 006620 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩11.52 Billion	4.28%
Total Liquid Assets	₩11.52 Billion	4.28%

Asset Resilience Insights

Limited Liquidity: DongKoo Bio&Pharma Co. Ltd maintains only 4.28% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

DongKoo Bio&Pharma Co. Ltd Industry Peers by Asset Resilience Ratio

Compare DongKoo Bio&Pharma Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sam Chun Dang Pharm. Co. Ltd KQ:000250	Pharmaceuticals	4.82%
ST Pharm Co.Ltd KQ:237690	Pharmaceuticals	7.72%
NatureCell Co.Ltd KQ:007390	Pharmaceuticals	0.00%
Oscotec Inc KQ:039200	Pharmaceuticals	65.38%
Caregen Co.Ltd KQ:214370	Pharmaceuticals	4.58%
Kolon Life Science Inc KQ:102940	Pharmaceuticals	1.22%
Mezzion Pharma Co.Ltd KQ:140410	Pharmaceuticals	13.09%
Komipharm International Co. Ltd KQ:041960	Pharmaceuticals	0.00%

Annual Asset Resilience Ratio for DongKoo Bio&Pharma Co. Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for DongKoo Bio&Pharma Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	14.85%	₩36.24 Billion ≈ $24.56 Million	₩244.06 Billion ≈ $165.40 Million	+2.87pp
2023-12-31	11.98%	₩22.90 Billion ≈ $15.52 Million	₩191.10 Billion ≈ $129.51 Million	-8.23pp
2022-12-31	20.22%	₩34.79 Billion ≈ $23.57 Million	₩172.06 Billion ≈ $116.60 Million	-0.43pp
2021-12-31	20.65%	₩31.96 Billion ≈ $21.66 Million	₩154.79 Billion ≈ $104.90 Million	+0.20pp
2020-12-31	20.44%	₩29.51 Billion ≈ $20.00 Million	₩144.35 Billion ≈ $97.83 Million	-4.17pp
2019-12-31	24.61%	₩32.67 Billion ≈ $22.14 Million	₩132.73 Billion ≈ $89.95 Million	+3.81pp
2018-12-31	20.80%	₩21.69 Billion ≈ $14.70 Million	₩104.28 Billion ≈ $70.67 Million	+6.27pp
2017-12-31	14.54%	₩10.99 Billion ≈ $7.45 Million	₩75.59 Billion ≈ $51.23 Million	+7.00pp
2016-12-31	7.54%	₩4.92 Billion ≈ $3.34 Million	₩65.31 Billion ≈ $44.26 Million	+7.14pp
2015-12-31	0.39%	₩240.00 Million ≈ $162.65K	₩60.77 Billion ≈ $41.18 Million	--

pp = percentage points

About DongKoo Bio&Pharma Co. Ltd

KQ:006620 Korea Pharmaceuticals

Market Cap

$26.72 Million

₩39.42 Billion KRW

Market Cap Rank

#24206 Global

#1681 in Korea

Share Price

₩4105.00

Change (1 day)

+0.12%

52-Week Range

₩3800.00 - ₩6090.00

All Time High

₩13745.55